Table 2.
Tumour type | PEDF action | Refs |
---|---|---|
Retinoblastoma |
|
1,2,39,59 |
Neuroblastoma |
|
40,72,174 |
Prostate |
|
35,47,68,104,157,175 |
Melanoma |
|
56,57,80,82,176 |
Wilms’ tumour |
|
51,52 |
Pancreatic adenocarcinoma |
|
47,53,79,83 |
Hepatoblastoma |
|
54 |
Osteosarcoma |
|
55,74,75,149,177,178 |
Chondrosarcoma |
|
76 |
Human cervical carcinoma |
|
60 |
Gastric carcinoma |
|
61 |
Nasopharyngeal carcinoma |
|
62 |
Lewis lung carcinoma |
|
63,144 |
Colorectal peritoneal carcinoma |
|
64,71,73 |
Glioma |
|
47,69,70,73,146 |
Uveal melanoma |
|
81,126 |
Breast cancer xenograft |
|
73,77 |
Brain metastasis from
breast tumours |
|
41,78 |
HIF1α, hypoxia-inducible factor 1α; MVD, microvessel density; PEDF, pigment epithelium-derived factor; VEGF, vascular endothelial growth factor.